Linezolid Market is anticipated to grow at a significant CAGR during the forecast period. Linezolid is an antibiotic drug that is used for the treatment of serious bacterial infections such as gram-positive bacteria, pneumonia, skin infections, and infections that are resistant to other antibiotics by stopping the growth of bacteria. This drug is either consumed by mouth or by injecting directly into the vein. The major factor for the growth of the market is the increasing prevalence of pneumonia.
According to the World Health Organization (WHO), in 2019, pneumonia accounted for 14% of all children mortality with a mortality rate of 740,180 children under the age of five. Additionally, as per UNICEF 2021, the mortality rate due to pneumonia is more than 800,000 children under five every year or around 2,200 every day which includes over 153,000 newborns. Further, there are more than 1,400 cases of pneumonia per 100,000 children or 1 case per 71 children every year globally. Hence, the rising prevalence of pneumonia is increasing the risk for bacterial infections creating demand for linezolid.
Some major players in the market include Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Alembic Pharmaceuticals Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2017, HQ SPCLT PHARMA announced that their Linezolid intravenous solution 200MG/100ML (2MG/ML), 600MG/300ML (2MG/ML) was approved by the FDA.
To Request a Sample of our Report on Linezolid Market: https://www.omrglobal.com/request-sample/linezolid-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Alembic Pharmaceuticals Inc., among others.
Linezolid Market Report by Segment
By Type
- Injection
- Tablets
By Application
- Hospital Acquired Pneumonia (HAP)
- Community Acquired Pneumonia (CAP)
- Complex Skin Or Skin Soft Tissue Infection (SSTI)
- Vancomycin-Resistant Enterococcus (VRE) Infection
- Others
A full Report of Global Linezolid Market is Available @ https://www.omrglobal.com/industry-reports/linezolid-market
Linezolid Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/linezolid-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
